Follow The Filings

MBIO Mustang Bio

Mustang Bio earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MBIO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MBIO insider trades
  • $238 bought by 1 insider
  • $241 sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Neil Herskowitz Director
    Sale
    $238 247 shares at $0.9600 63% of stake
    Traded Dec 30, 2025 Filed Dec 30, 2025
    ↗
  2. Adam J. Chill Director
    Sale
    $4 4 shares at $0.9600 1.1% of stake
    Traded Dec 30, 2025 Filed Dec 30, 2025
    ↗
  3. David Jin Director
    Buy
    $238 247 shares at $0.9600 +633% to stake
    Traded Dec 30, 2025 Filed Dec 30, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 1 stock grant and 1 share withholding for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
10-Q Filing Doc
10-Q Filing Doc
8-K 3.01 Filing Doc
10-K Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.07,8.01,9.01 Filing Doc
DEF 14A Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
424B5 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
424B3 Filing Doc
10-K Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.01,8.01,9.01 Filing Doc
424B3 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.